utrition supplement for tube feeding assessed in hospitalized (ICU Stay) patients
- Conditions
- Health Condition 1: Z209- Contact with and (suspected) exposure to unspecified communicable disease
- Registration Number
- CTRI/2022/12/047818
- Lead Sponsor
- Dr Reddys Laboratories
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1) To study the impact of tube feeding supplement for achieving the target Macro Nutrients levels
2) To study the number of days required to reach the target Macro Nutrients levels
1) To study the impact of EN supplement on total protein, micronutrient levels such as Zn, Vitamin C, Mg, potassium and Phosphorous.
2) To study the impact of tube feeding supplement events of abdominal pain, distension, vomiting and diarrhea after EN supplement
3) To assess the number and reasons of interruptions during the tube feeding and ease of titration of the formula
4) To assess the impact of tube feeding supplement on hematological parameters from baseline to the end of the study.
5) To evaluate the palatability of the formulation in patients shifted to ward’s, through oral supplementation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Ease of achieving desired target, no. of days required to achieve the target and no. of days of ICU stay. <br/ ><br>Timepoint: Baseline Visit, Day 1, Day 2, Day 3, Day 4-8, Day 8-14, End of study assessment.
- Secondary Outcome Measures
Name Time Method 1) Improved vital status <br/ ><br>2) No Interruptions to feeding <br/ ><br>3) Absence of GIT complications- abdominal distention, vomiting and pain post starting of EN <br/ ><br>4) Biochemical profile changes like blood glucose, BUN, LFT, Serum Pre albumin Levels <br/ ><br>5) Palatability of the powder in ward patientsTimepoint: Baseline Visit, Day 1, Day 2, Day 3, Day 4-8, Day 8-14, End of study assessment.